Eli Lilly and Company's Fiscal Year is From January To December.
The item "Working-Capital-Turnover" stands at 4.92 as of 09/30/2025, the lowest value at least since 06/30/2022, the period currently displayed.
As of the end of Eli Lilly and Company's third quarter, the item "Working Capital Turnover" stands at 4.92. This represents a decrease of -23.50 percent compared to it's value at the end of it's second quarter .
Regarding the One-Year-Change of the series, the current value constitutes a decrease of -55.32 percent compared to the value the year prior.
The 1 year change in percent is -55.32.
The 3 year change in percent is -56.01.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Johnson & Johnson - Working Capital Turnover | 486,508,953,600.00 |
![]() | AbbVie Inc - Working Capital Turnover | 399,570,305,024.00 |
![]() | Roche Holding AG - Working Capital Turnover | 317,433,206,677.55 |
![]() | AstraZeneca PLC - Working Capital Turnover | 280,205,508,085.11 |
![]() | Novartis AG - Working Capital Turnover | 255,096,620,580.91 |